Smart deals start with the right connections.
Access 800+ qualified LPs through CQ’s Investor Database.
Overview and Management
Establishment Year
1999
Mission
To build sustainable, research-driven enterprises that improve human lives.
Values
Flexible capital, strategic insights, operational resources, and collaboration with world-class teams.
Investment Roles
General Partner (GP)
Participant Demographics
Not specified. Likely focused on life sciences companies and associated stakeholders.
Generational Wealth Planning
Risk Tolerance
Not explicitly mentioned; focus on venture capital indicates a higher risk tolerance.
References or Case Studies
Portfolio highlights provided; no explicit mention of references or case studies availability.
Team Experience
Notable Achievements
Investments in IPOs and acquisitions, such as Aileron Therapeutics, Akero Therapeutics, and Chinook Therapeutics.
Project Track Record
Includes investments in companies such as Aethon Therapeutics, Aulos Bioscience, and others.
Exit Strategies
IPOs and acquisitions (e.g., Chinook Therapeutics acquired by Novartis AG, Tendyne acquired by Abbott).
Legal, Compliance and Contact Information
Regulatory Registrations
Compliance History
info@appletreepartners.com
Phone Number
212-468-5800
Address
New York United States